Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor
Recruiting
Observational Study
Cognitive Decline
Urinary Bladder Cancer
Frail
Biomarker
General Anesthesia
Hand Grip Strength
Cognitive Testing
Comorbidities
Demographic Data
Socio-economic Status
Perioperative Complications
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 42 (estimated)
- Sponsor
- Osijek University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Bladder tumor is one of the most widespread tumors in the world, with increasing prevalence at the global level. One of the procedures in patients with bladder tumors is transurethral resection of the bladder (TURM) most often performed endoscopically under general anesthesia. This patient population has certain characteristics in common. One of them is exposure to common risk factors for the form…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adult patients from 18-80 years,
* elective operations of tumor bladder cancer (TUR),
* patients can communicate,
* patients who can sign the information consent and questionnaires
Exclusion Criteria:
* patients under the age of 18,
* patients above 80 years,
* patients who …
Contacts